Waiving Intellectual Property Rules Key to Beating Covid-19

With two companies, Pfizer and BioNTech, having announced promising early results for a Covid-19 vaccine they are developing, governments in the United States, Europe and the United Kingdom are racing to prebook hundreds of millions of doses for their own use. But as long as intellectual property rights limit the production of and access to Covid-19 vaccines that are found to be safe and effective, the world is headed down a dangerous path, as such vaccines will remain out of reach for most low- and middle-income countries. Those pushing to share the benefits of science widely to protect people’s…

Read complete article

~	Kenya floods: as the costs add up pressure mounts on a country in economic crisis

~	Grattan on Friday: Like the famous budget tree, Chalmers can change the story to suit the season

~	Billions are needed for climate adaptation – now some frontline communities are deciding how the money gets spent

~	Cancer: here’s the role exercise plays, from prevention to treatment

~	Why removing protections on social media – in the name of free speech – is bad for peacebuilding

~	Falling house prices won’t open new doors – for buyers or renters

~	You Are Here by David Nicholls – a touching tale of finding love and connection in nature

~	5 books to help you better understand today’s campus protests

~	Little seed, big problem – keep an eye out for foxtail seed pods that can harm your pet this summer

~	Section 702 foreign surveillance law lives on, but privacy fight continues